COURT-RULING ·Filed Feb 24, 2026

FMS

Fresenius Medical Care North America
NEUTRAL
Impact 1/10
Horizonimmediate Processed4mo ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight • Neutral

This ruling has no material impact on FMS. The case was a pro se patient complaint with no viable legal theories and zero financial exposure. No further monitoring required.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
FMS ▼ -2.47% at T+60d
NEUTRAL call ✗ call lost -2.47% · α vs SPY -9.22% · entry $22.66 → $22.10
Entry anchored
Feb 23, 03:59 PM ET
via exchange tick
T+1d
-0.04%
call -0.04% · α -0.88%
$22.65
settled 7mo ago
T+5d
+3.13%
call +3.13% · α +4.16%
$23.37
settled 7mo ago
T+20d
-2.78%
call -2.78% · α +2.21%
$22.03
settled 6mo ago
T+60d
-2.47%
call -2.47% · α -9.22%
$22.10
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

The court granted motions to dismiss all claims against Fresenius Medical Care North America employees in a pro se patient lawsuit, finding no private right of action under criminal statutes, HIPAA, or UN declarations, and no state action for constitutional claims. The ruling eliminates a frivolous litigation risk with no financial exposure for FMS.

Court Ruling Details

Ruling Date
Feb 24, 2026
Court
United States District Court for the Eastern District of Pennsylvania
Court Level
District
Judge
Chad F. Kenney
Case Type
other
Ruling Type
motion to dismiss
Outcome
WIN — ruling favors this company
Will It Be Appealed?
Unlikely
Precedent Risk
LOW
Market Cap Exposure
0%

Key Facts

  • Court dismissed all 19 counts against Fresenius employees for lack of subject matter jurisdiction and failure to state a claim.
  • Plaintiff's claims under criminal statutes, HIPAA, and UN declarations had no private right of action.
  • Constitutional claims failed because defendants were private actors, not state actors.
  • Remaining state law claims were dismissed without prejudice as court declined supplemental jurisdiction.
  • No damages were sought or awarded; the case involved no financial exposure to FMS.

Financial Impact

No financial impact — case dismissed with no damages sought or awarded.

Risk Factors

  • Plaintiff could refile state law claims in state court, but the dismissed federal claims are unlikely to succeed.

Market Snapshot

Exchange
OTC
Sector
Services-Misc Health & Allied Services, NEC
Analyst Consensus
41% bullish (27 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-15tq1o16-FMS
8 reports for FMS
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+60▲ +3.43%Apr 7, 2026
Filters
Rows
Reports for FMS — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
Court Ruling
NEUTRAL ★ 1/10
$22.74 $22.38▼ −1.58%▼ −1.90%$22.25 (−2.15%)
Aug 31, 2026
4w ago
Court Ruling
NEUTRAL ★ 4/10
$22.74 $22.27▼ −2.07%▼ −1.88%$22.25 (−2.15%)
Aug 27, 2026
5w ago
6-K
BULLISH ★ 5/10
$23.27 $22.35▼ −3.95%▼ −3.45%$22.25 (−4.38%)
Aug 4, 2026
8w ago
6-K
MIXED ★ 5/10
$24.01 $22.74▼ −5.29%▼ −4.05%$22.25 (−7.33%)
Jun 29, 2026
13w ago
Court Ruling
NEUTRAL ★ 1/10
$22.70 $24.59▲ +8.33%▲ +8.61%$22.25 (−1.98%)
Apr 7, 2026
25w ago
Court Ruling
BULLISH ★ 7/10
$22.75 $22.65▼ −0.44%▼ −10.22%$22.25 (−2.20%)
Mar 30, 2026
26w ago
Court Ruling
BEARISH ★ 6/10
$22.21 $22.51▼ −1.35%▲ +11.25%$22.25 (−0.18%)
Feb 24, 2026
31w ago
Court Ruling
NEUTRAL ★ 1/10
$22.66 $22.03▼ −2.78%▲ +2.21%$22.25 (−1.81%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (38h 29m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access